DexCom recently reported preliminary fourth-quarter results showing year-over-year revenue growth in both U.S. and ...
SHANGHAI, CHINA - JANUARY 25, 2022 - A 3M logo display of air-condensed thermal materials in a shopping mall in Shanghai, China, January 25, 2022. (Photo credit should read Wang Gang / Costfoto/Future ...
DexCom's returns over the past decade have been solid, but not quite on par with the market's. The company has encountered some headwinds in recent years that have sunk its stock price. Despite the ...
DexCom's stock fell sharply after mixed Q2 earnings and lowering full-year guidance, signaling a revaluation phase with lower growth expectations. Revenue guidance was cut from $4.2-$4.35 billion to ...
Dexcom is working closely with its insulin pump partners to ensure that Dexcom G7 15 Day will be compatible with automated insulin delivery systems upon launch. Dexcom G7 15 Day is expected to launch ...
Dexcom (($DXCM)) has held its Q3 earnings call. Read on for the main highlights of the call. DexCom’s recent earnings call conveyed a generally ...
DexCom's growth rate has been accelerating for multiple quarters, and recently came in at around 22%. A rise in GLP-1 drugs has some investors concerned that DexCom's growth opportunities may be ...
DexCom presented outlook on diabetes market at the ADA Conference, highlighting potential for growth with new products like Stelo and DexCom ONE. DexCom's strategy differs from Abbott Labs, focusing ...
Since it is offering 30,000 square feet of its warehouse to create Arizona’s first indoor, drive-thru COVID-19 vaccine center, it’s tempting to rebrand Dexcom as “vaxcom.” Jim Kasselmann, senior ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results